These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 30565334

  • 41. Heart-fatty acid binding protein in dogs with degenerative valvular disease and dilated cardiomyopathy.
    Lam C, Casamian-Sorrosal D, Monteith G, Fonfara S.
    Vet J; 2019 Feb; 244():16-22. PubMed ID: 30825889
    [Abstract] [Full Text] [Related]

  • 42. Serial analysis of serum cardiac troponin I changes and correlation with clinical findings in 46 dogs with mitral valve disease.
    Polizopoulou ZS, Koutinas CK, Dasopoulou A, Patsikas M, York M, Roman I, Gandhi M, Patel S, Koutinas AF, O'Brien PJ.
    Vet Clin Pathol; 2014 Jun; 43(2):218-25. PubMed ID: 24612252
    [Abstract] [Full Text] [Related]

  • 43. Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
    Kaplan JL, Visser LC, Gunther-Harrington CT, Ontiveros ES, Wittenburg LA, Palm CA, Stern JA.
    J Vet Intern Med; 2022 Nov; 36(6):1892-1899. PubMed ID: 36098206
    [Abstract] [Full Text] [Related]

  • 44. Plasma atrial natriuretic peptide (proANP 31-67), B-type natriuretic peptide (Nt-proBNP) and endothelin-1 (ET-1) concentrations in dogs with chronic degenerative valvular disease (CDVD).
    Piantedosi D, Cortese L, Di Loria A, Brignola G, Prisco M, Persechino A, Ciaramella P.
    Vet Res Commun; 2009 Sep; 33 Suppl 1():197-200. PubMed ID: 19585255
    [No Abstract] [Full Text] [Related]

  • 45. Heritability of premature mitral valve disease in Cavalier King Charles spaniels.
    Lewis T, Swift S, Woolliams JA, Blott S.
    Vet J; 2011 Apr; 188(1):73-6. PubMed ID: 20347358
    [Abstract] [Full Text] [Related]

  • 46. Galectin-3 in cardiac muscle and circulation of dogs with degenerative mitral valve disease.
    Sakarin S, Rungsipipat A, Surachetpong SD.
    J Vet Cardiol; 2016 Mar; 18(1):34-46. PubMed ID: 26786977
    [Abstract] [Full Text] [Related]

  • 47. Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    J Vet Cardiol; 2012 Sep; 14(3):399-408. PubMed ID: 22858663
    [Abstract] [Full Text] [Related]

  • 48. Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease.
    Lee CM, Han JI, Kang MH, Kim SG, Park HM.
    J Vet Sci; 2018 Jan 31; 19(1):129-135. PubMed ID: 28693307
    [Abstract] [Full Text] [Related]

  • 49. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 31; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 50. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
    Arndt JW, Reynolds CA, Singletary GE, Connolly JM, Levy RJ, Oyama MA.
    J Vet Intern Med; 2009 Dec 31; 23(6):1208-13. PubMed ID: 19709352
    [Abstract] [Full Text] [Related]

  • 51. Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation.
    Wall L, Mohr A, Ripoli FL, Schulze N, Penter CD, Hungerbuehler S, Bach JP, Lucas K, Nolte I.
    PLoS One; 2018 Dec 31; 13(6):e0199023. PubMed ID: 29902265
    [Abstract] [Full Text] [Related]

  • 52. Veterinary Medicine and Multi-Omics Research for Future Nutrition Targets: Metabolomics and Transcriptomics of the Common Degenerative Mitral Valve Disease in Dogs.
    Li Q, Freeman LM, Rush JE, Huggins GS, Kennedy AD, Labuda JA, Laflamme DP, Hannah SS.
    OMICS; 2015 Aug 31; 19(8):461-70. PubMed ID: 26154239
    [Abstract] [Full Text] [Related]

  • 53. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
    Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M.
    J Am Vet Med Assoc; 2008 May 15; 232(10):1496-503. PubMed ID: 18479239
    [Abstract] [Full Text] [Related]

  • 54. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
    Zhang B, Xu H, Zhang H, Liu Q, Ye Y, Hao J, Zhao Q, Qi X, Liu S, Zhang E, Xu Y, Gao R, Pibarot P, Clavel MA, Wu Y, CHINA-DVD Collaborators.
    J Am Coll Cardiol; 2020 Apr 14; 75(14):1659-1672. PubMed ID: 32273031
    [Abstract] [Full Text] [Related]

  • 55. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E, Kresken JG, Henrich E, Hildebrandt N, Schneider C, Stosic A, Schneider M.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Apr 14; 40(3):171-9. PubMed ID: 22688794
    [Abstract] [Full Text] [Related]

  • 56. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
    Markby GR, Macrae VE, Corcoran BM, Summers KM.
    BMC Vet Res; 2020 Sep 23; 16(1):350. PubMed ID: 32967675
    [Abstract] [Full Text] [Related]

  • 57. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE.
    J Vet Intern Med; 2009 Sep 23; 23(6):1190-6. PubMed ID: 19780931
    [Abstract] [Full Text] [Related]

  • 58. Chronic valvular disease in the cavalier King Charles spaniel in Sweden.
    Häggström J, Hansson K, Kvart C, Swenson L.
    Vet Rec; 1992 Dec 12; 131(24):549-53. PubMed ID: 1481344
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM, DeClue AE, Reinero CR.
    J Am Vet Med Assoc; 2008 Jun 01; 232(11):1674-9. PubMed ID: 18518809
    [Abstract] [Full Text] [Related]

  • 60. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
    Besche B, Blondel T, Guillot E, Garelli-Paar C, Oyama MA.
    J Vet Intern Med; 2020 Sep 01; 34(5):1746-1758. PubMed ID: 32767627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.